| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.008 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.008 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |